Charming Medical (MCTA) CEO reports Class A and B share stakes

Rhea-AI Filing Summary

Charming Medical Ltd director and Chief Executive Officer Wong Kit Christine has filed an initial statement of ownership. She reports holding 10,350,360 Class A ordinary shares and 2,000,000 Class B ordinary shares, each with a par value of US$0.0001 per share.

These positions are reported as direct ownership, and the filing does not show any new purchases or sales, only the share balances following the reporting date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Wong Kit Christine

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Class A ordinary shares, par value US$0.0001 per share	--	--	--
holding	Class B ordinary shares, par value US$0.0001 per share	--	--	--

Holdings After Transaction: Class A ordinary shares, par value US$0.0001 per share — 10,350,360 shares (Direct); Class B ordinary shares, par value US$0.0001 per share — 2,000,000 shares (Direct)

Footnotes (1)

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wong Kit Christine

(Last) (First) (Middle)

UNITS 1803-1806, 18/F, HANG LUNG CENTRE

2-20 PATERSON STREET, CAUSEWAY BAY

(Street)

HONG KONG 00000

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Charming Medical Ltd [ MCTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A ordinary shares, par value US$0.0001 per share	10,350,360	D
Class B ordinary shares, par value US$0.0001 per share	2,000,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kit Wong	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Charming Medical (MCTA) CEO Wong Kit Christine report owning in this Form 3?

She reports direct ownership of 10,350,360 Class A ordinary shares and 2,000,000 Class B ordinary shares. These figures reflect her beneficial stake after the reporting date, without indicating any new purchases or sales activity in this filing.

Is the Charming Medical (MCTA) Form 3 a buy or sell transaction?

This Form 3 does not record a buy or sell transaction; it reports existing holdings. The filing lists share balances for Class A and Class B ordinary shares, serving as an initial disclosure of beneficial ownership by the CEO and director.

How many Class A shares does the Charming Medical (MCTA) CEO directly hold?

The CEO directly holds 10,350,360 Class A ordinary shares, par value US$0.0001 per share. This number represents her beneficial ownership after the reporting date as disclosed, not a newly executed trade or option exercise.

How many Class B shares are reported in the Charming Medical (MCTA) Form 3?

The Form 3 reports direct beneficial ownership of 2,000,000 Class B ordinary shares. These are separate from her Class A holdings and together outline her overall equity position and potential voting influence in the company at that time.

Does the Charming Medical (MCTA) Form 3 show any derivative securities or options?

The filing shows no derivative securities or options; the derivative section is empty. It focuses solely on ordinary share holdings, detailing Class A and Class B positions held directly by the reporting insider after the reporting date.